While concerns about a potential US recession persist, growth stocks have continued to outperform value stocks in 2024.

Unlicensed pharmacies purporting to sell pharmaceutical drugs are thriving despite the efforts by the U.S. Drug Enforcement Administration to stop them.

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

The company saw big bills related to cancer, premature births and hospital prices driving up claim severity in the fourth ...

Prices for brand-name drugs in the U.S. are three times what the same drugs cost in other countries. And in a recent KFF survey, 3 in 10 adults reported not taking their medicine as prescribed at some ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

With Trump in office and Republicans controlling Congress, it’s time for the president to continue work he started and ...

Among the common goods that are made in China are many generic prescription drugs and pharmacists are worried that those ...

Republicans (78%) were more likely than Democrats (4%) and independents (27%) to say Trump’s drug price agenda was moving the ...

See Upcoming Dividends for all ASX companies.

Instead of lowering drug prices, the agency's proposed implementation will increase drug purchasing costs, according to the ASHP and the National Community Pharmacists Association. An NCPA survey ...